Eleva
Freiburg
About Eleva
Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce supreme biologics like antibodies, replacement enzymes, or fusion toxins. Eleva has successfully developed drug candidates into clinical phases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $74.0M
- Last round: Series Unknown (Jan 2021)
- Website: elevabiologics.com
- Phone: +49 761 470 99 0
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eleva-57365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.